Nonscreened Patients With Breast Cancer Need More Treatment Than Screened Patients Screening women aged 40 to 49 for breast cancer has additional benefits beyond the proven decrease in mortality rate, according to researchers at Case Western Reserve University. Patients screened with mammography are statistically less likely to undergo chemotherapy, avoiding the associated toxic morbidities. Screening
Automated breast density measurement predicts breast cancer risk in younger women, and that risk may be related to the rate at which breast density changes in some women as they age, according to research presented at RSNA 2013. Breast density, as determined by mammography, already is known to be a strong and independent risk factor
Experts from both the Fraunhofer Institute for Biomedical Engineering IBMT in St Ingbert, Germany, and the Fraunhofer Institute for Medical Image Computing MEVIS in Bremen, Germany, are working together on the MARIUS (magnetic resonance imaging using ultrasound) project, developing a quicker, gentler, more cost-effective biopsy method that is easier on breast cancer patients. The new